Fidelity Select Biotechnology Portfolio (FBIOX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
18.07
+0.24 (1.35%)
Jun 4, 2025, 8:09 AM EDT
FBIOX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 13.05% |
2 | AMGN | Amgen Inc. | 10.22% |
3 | KRYS | Krystal Biotech, Inc. | 8.46% |
4 | GILD | Gilead Sciences, Inc. | 7.04% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.68% |
6 | VRTX | Vertex Pharmaceuticals Incorporated | 3.80% |
7 | REGN | Regeneron Pharmaceuticals, Inc. | 3.31% |
8 | ASND | Ascendis Pharma A/S | 2.57% |
9 | ARGX | argenx SE | 2.54% |
10 | EBR: UCB | UCB SA | 2.34% |
11 | INSM | Insmed Incorporated | 1.85% |
12 | CORT | Corcept Therapeutics Incorporated | 1.44% |
13 | CPH: ZEAL | Zealand Pharma A/S | 1.41% |
14 | ACLX | Arcellx, Inc. | 1.32% |
15 | SRRK | Scholar Rock Holding Corporation | 1.31% |
16 | NTRA | Natera, Inc. | 1.22% |
17 | IRON | Disc Medicine, Inc. | 1.10% |
18 | SMMT | Summit Therapeutics Inc. | 1.08% |
19 | CNTA | Centessa Pharmaceuticals plc | 1.07% |
20 | TGTX | TG Therapeutics, Inc. | 0.93% |
21 | MRUS | Merus N.V. | 0.90% |
22 | AVBP | ArriVent BioPharma, Inc. | 0.89% |
23 | n/a | Bio Ab2 Holdings Llc Arc | 0.81% |
24 | BPMC | Blueprint Medicines Corporation | 0.80% |
25 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.79% |
26 | BHVN | Biohaven Ltd. | 0.79% |
27 | CADL | Candel Therapeutics, Inc. | 0.78% |
28 | PCVX | Vaxcyte, Inc. | 0.77% |
29 | UTHR | United Therapeutics Corporation | 0.76% |
30 | SWX: GALD | Galderma Group AG | 0.65% |
31 | n/a | Bridgebio Pharma Inc Pipe | 0.63% |
32 | MRNA | Moderna, Inc. | 0.54% |
33 | MNKD | MannKind Corporation | 0.53% |
34 | PTGX | Protagonist Therapeutics, Inc. | 0.52% |
35 | n/a | National Resilience B Pc Pp | 0.51% |
36 | RNA | Avidity Biosciences, Inc. | 0.50% |
37 | MLTX | MoonLake Immunotherapeutics | 0.50% |
38 | n/a | Cash | 0.49% |
39 | n/a | Metsera 180day Lu Line 7/30/25 | 0.49% |
40 | NUVL | Nuvalent, Inc. | 0.48% |
41 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.45% |
42 | XENE | Xenon Pharmaceuticals Inc. | 0.44% |
43 | PTCT | PTC Therapeutics, Inc. | 0.41% |
44 | BNTX | BioNTech SE | 0.38% |
45 | IONS | Ionis Pharmaceuticals, Inc. | 0.38% |
46 | EXEL | Exelixis, Inc. | 0.37% |
47 | RVMD | Revolution Medicines, Inc. | 0.37% |
48 | APGE | Apogee Therapeutics, Inc. | 0.37% |
49 | NAMS | NewAmsterdam Pharma Company N.V. | 0.34% |
50 | RARE | Ultragenyx Pharmaceutical Inc. | 0.33% |
51 | VRNA | Verona Pharma plc | 0.33% |
52 | ROIV | Roivant Sciences Ltd. | 0.32% |
53 | SLDB | Solid Biosciences Inc. | 0.32% |
54 | VRDN | Viridian Therapeutics, Inc. | 0.32% |
55 | VKTX | Viking Therapeutics, Inc. | 0.32% |
56 | SPRY | ARS Pharmaceuticals, Inc. | 0.31% |
57 | VERA | Vera Therapeutics, Inc. | 0.29% |
58 | IMVT | Immunovant, Inc. | 0.28% |
59 | IDYA | IDEAYA Biosciences, Inc. | 0.28% |
60 | RCUS | Arcus Biosciences, Inc. | 0.27% |
61 | n/a | Bio Ab2 Holdings Llc Adi | 0.27% |
62 | NUVB | Nuvation Bio Inc. | 0.26% |
63 | JANX | Janux Therapeutics, Inc. | 0.25% |
64 | SLNO | Soleno Therapeutics, Inc. | 0.24% |
65 | EPA: ALSEN | Sensorion SA | 0.23% |
66 | RNAC | Cartesian Therapeutics, Inc. | 0.22% |
67 | AKRO | Akero Therapeutics, Inc. | 0.22% |
68 | ELVN | Enliven Therapeutics, Inc. | 0.22% |
69 | PRTA | Prothena Corporation plc | 0.21% |
70 | GOSS | Gossamer Bio, Inc. | 0.21% |
71 | AXSM | Axsome Therapeutics, Inc. | 0.21% |
72 | NRIX | Nurix Therapeutics, Inc. | 0.20% |
73 | ATYR | aTyr Pharma, Inc. | 0.19% |
74 | ORKA | Oruka Therapeutics, Inc. | 0.18% |
75 | BEAM | Beam Therapeutics Inc. | 0.18% |
76 | SDGR | Schrödinger, Inc. | 0.17% |
77 | DAWN | Day One Biopharmaceuticals, Inc. | 0.17% |
78 | n/a | Triveni Bio Inc Series B Pc Pp | 0.17% |
79 | COGT | Cogent Biosciences, Inc. | 0.16% |
80 | SWTX | SpringWorks Therapeutics, Inc. | 0.16% |
81 | NTLA | Intellia Therapeutics, Inc. | 0.16% |
82 | n/a | Fidelity Cash Central Fund | 0.15% |
83 | DYN | Dyne Therapeutics, Inc. | 0.14% |
84 | GHRS | GH Research PLC | 0.13% |
85 | IMCR | Immunocore Holdings plc | 0.13% |
86 | TWST | Twist Bioscience Corporation | 0.13% |
87 | TECX | Tectonic Therapeutic, Inc. | 0.13% |
88 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.12% |
89 | TSHA | Taysha Gene Therapies, Inc. | 0.12% |
90 | DNLI | Denali Therapeutics Inc. | 0.12% |
91 | SYRE | Spyre Therapeutics, Inc. | 0.11% |
92 | n/a | Cardurion Pharmace Ser B Pc Pp | 0.11% |
93 | GPCR | Structure Therapeutics Inc. | 0.11% |
94 | QURE | uniQure N.V. | 0.11% |
95 | n/a | Immunovant Inc Pipe | 0.11% |
96 | ABSI | Absci Corporation | 0.11% |
97 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.10% |
98 | LEGN | Legend Biotech Corporation | 0.10% |
99 | ALEC | Alector, Inc. | 0.09% |
100 | n/a | Antares Therapeutics Inc | 0.09% |
101 | CYTK | Cytokinetics, Incorporated | 0.09% |
102 | NVO | Novo Nordisk A/S | 0.09% |
103 | KYMR | Kymera Therapeutics, Inc. | 0.09% |
104 | WVE | Wave Life Sciences Ltd. | 0.09% |
105 | n/a | Neurona Thercs Inc F Pc Prp Pp | 0.08% |
106 | ETNB | 89bio, Inc. | 0.08% |
107 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.08% |
108 | DSGN | Design Therapeutics, Inc. | 0.08% |
109 | PHAT | Phathom Pharmaceuticals, Inc. | 0.08% |
110 | STOK | Stoke Therapeutics, Inc. | 0.08% |
111 | VTVT | vTv Therapeutics Inc. | 0.08% |
112 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.07% |
113 | n/a | Tectonic Therapeutic Inc Pipe | 0.07% |
114 | ATXS | Astria Therapeutics, Inc. | 0.07% |
115 | DNTH | Dianthus Therapeutics, Inc. | 0.07% |
116 | EXAS | Exact Sciences Corporation | 0.07% |
117 | KROS | Keros Therapeutics, Inc. | 0.07% |
118 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.07% |
119 | VIR | Vir Biotechnology, Inc. | 0.06% |
120 | ONC | BeOne Medicines Ltd. | 0.06% |
121 | REPL | Replimune Group, Inc. | 0.06% |
122 | n/a | Cartesian Therapeutics ([Wts/Rts]) | 0.06% |
123 | UPB | Upstream Bio, Inc. | 0.06% |
124 | n/a | Crescent Biopharma Inc Pipe | 0.06% |
125 | BBIO | BridgeBio Pharma, Inc. | 0.05% |
126 | HRMY | Harmony Biosciences Holdings, Inc. | 0.05% |
127 | LENZ | LENZ Therapeutics, Inc. | 0.05% |
128 | n/a | Jade Biosciences Inc Pipe | 0.05% |
129 | n/a | Candid Therapeutic Ser B Pc Pp | 0.05% |
130 | PHVS | Pharvaris N.V. | 0.04% |
131 | ZBIO | Zenas BioPharma, Inc. | 0.04% |
132 | RAPP | Rapport Therapeutics, Inc. | 0.04% |
133 | GERN | Geron Corporation | 0.04% |
134 | MAZE | Maze Therapeutics, Inc. | 0.04% |
135 | TYRA | Tyra Biosciences, Inc. | 0.04% |
136 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.04% |
137 | CATX | Perspective Therapeutics, Inc. | 0.04% |
138 | GLUE | Monte Rosa Therapeutics, Inc. | 0.04% |
139 | EWTX | Edgewise Therapeutics, Inc. | 0.04% |
140 | CGON | CG Oncology, Inc. | 0.03% |
141 | ALLO | Allogene Therapeutics, Inc. | 0.03% |
142 | ANAB | AnaptysBio, Inc. | 0.03% |
143 | MTSR | Metsera, Inc. | 0.03% |
144 | CRSP | CRISPR Therapeutics AG | 0.03% |
145 | CAMP | Camp4 Therapeutics Corporation | 0.03% |
146 | INZY | Inozyme Pharma, Inc. | 0.03% |
147 | TRDA | Entrada Therapeutics, Inc. | 0.03% |
148 | TXG | 10x Genomics, Inc. | 0.02% |
149 | BCAX | Bicara Therapeutics Inc. | 0.02% |
150 | BMEA | Biomea Fusion, Inc. | 0.02% |
151 | AVIR | Atea Pharmaceuticals, Inc. | 0.02% |
152 | RXRX | Recursion Pharmaceuticals, Inc. | 0.02% |
153 | IMNM | Immunome, Inc. | 0.02% |
154 | APLS | Apellis Pharmaceuticals, Inc. | 0.02% |
155 | ANNX | Annexon, Inc. | 0.02% |
156 | GERNW | Geron Corporation | 0.02% |
157 | n/a | Korro Bio Inc Pipe | 0.01% |
158 | GKOS | Glaukos Corporation | 0.01% |
159 | n/a | Elevatebio Llc Ser C Pc Pp | 0.01% |
160 | SANA | Sana Biotechnology, Inc. | 0.01% |
161 | RZLT | Rezolute, Inc. | 0.01% |
162 | n/a | Scholar Rock Wt 12/31/25 Pp | 0.01% |
163 | SWX: IDIA | Idorsia Ltd | 0.01% |
164 | FHTX | Foghorn Therapeutics Inc. | 0.01% |
165 | NVCR | NovoCure Limited | 0.00% |
166 | AURA | Aura Biosciences, Inc. | 0.00% |
167 | n/a | Warrant on Astria Therapeutics Inc | 0.00% |
168 | SRPT | Sarepta Therapeutics, Inc. | 0.00% |
169 | BOLD | Boundless Bio, Inc. | 0.00% |
170 | n/a | Cyclerion Therptcs Inc Pp Pipe | 0.00% |
171 | CLDX | Celldex Therapeutics, Inc. | 0.00% |
172 | n/a | Optinose ([Wts/Rts]) | 0.00% |
173 | n/a | Antares Therapeutics Inc Cvr | 0.00% |
174 | n/a | Antares Adjustment Escrow Line | 0.00% |
175 | n/a | Antares Indemnity Escrow Line | 0.00% |
176 | n/a | Antares Shareholder Rep Escrow | 0.00% |
177 | n/a | Disc Medicine Inc Cvr Rt | 0.00% |
178 | GRTSQ | Gritstone bio, Inc. | 0.00% |
179 | n/a | Aradigm Corp | 0.00% |
180 | n/a | Warrant on Chinook Energy Inc | 0.00% |
181 | n/a | Allena Pharmaceuticals Inc | 0.00% |
182 | n/a | Axcella Health Inc | 0.00% |
183 | n/a | Medavail Holdings Inc Pipe | 0.00% |
184 | n/a | Afferent Pharma Ser C Pc Pp | 0.00% |
185 | n/a | Saliogen Therapeut Ser B Pc Pp | 0.00% |
186 | n/a | Aradigm Corp | 0.00% |
187 | n/a | Deferred Tax Liability | -0.17% |
As of Mar 31, 2025